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Extract ofMyrica ceriferabarkhas longbeen fruitfully used as a hepato-protective and anti-
cancer drug in various complementary and alternative systems ofmedicine.Myricanone, its
principal bioactive compound, had also been reported to have apoptosis-promoting ability.
We evaluated its anti-cancer potential in vitro in HepG2 liver cancer cells and tried to un-
derstand the signal cascades involved in accomplishing apoptosis. Further, we ascertained
by using a (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay (MTT)
assay if it had cytotoxic effects on normal noncancerous liver cells (WRL-68). We deployed
various tools and protocols, like phase contrast, scanning electron andfluorescencemicros-
copies, performed an annexinV-FITC/PI assay and cell cycle analysis, and estimated the
reactive oxygen species (ROS) generation and mitochondrial membrane depolarization
through flow cytometry. Further, analyses of cytochrome-c translocation and of HSP70
and caspase expressions were also done by using immunoblota and Enzyme linked immuno-
sorbent assay (ELISA). Results revealed that myricanone induced apoptosis in HepG2 cells
through generation of ROS, depolarization of the mitochondrial membrane, early release
of cytochrome-c, down-regulation of HSP70 and activation of a caspase cascade; it had
no, or insignificant, cytotoxic effects inWRL-68 cells in vitro and inmice in vivo. Thus,myr-
icanone has great potential for use in formulating an effective drug against both hepatotox-
icity and hepatocellular cancer.s and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani 741235,
hudabukhsh_48@rediffmail.com (A.R. Khuda-Bukhsh).
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Myricanone Induces Apoptosis in HepG2 cells 1891. IntroductionThe prevalence of cancer is increasing worldwide despite
diagnostic and therapeutic advancements. Hepatocellular
carcinoma (HCC) is the most common type of liver cancer.
Treatment options for HCC are limited, because radiation
therapies are not recommended owing to the severe da-
mage they inflict on liver tissues, and chemotherapies
are only regionally effective [1]. Moreover, nonselective
distribution of drugs, enhanced drug toxicity, and un-
desirable side effects aggravate the challenges for
chemotherapy.
Heat shock protein 70 (HSP70), a molecular chaperone,
is abundantly expressed in malignant tumors of various
origins, which promotes tumorigenesis via its prosurvival
function. HSP70 is a major inhibitor of apoptosis induced by
chemotherapeutic agents [2,3]. Therefore, the search is on
for the development of a drug that should ideally have an
antiproliferative effect, arrest cell cycle, and also induce
apoptosis of cancer cells, either through the activation of
caspase cascades or by blocking HSP70 and other anti-
apoptotic genes.
Complementary and alternative medicine practices have
become popular, particularly in oncology, to provide a better
quality of life to cancer patients by alleviating their suffer-
ings [4,5]. Medicinal plant extracts and their bioactive
components that demonstrate significant potential as anti-
cancer therapeutic agents owing to their ability to inhibit
tumor growth, angiogenesis, and metastasis with minimal
side effects [6] are being seriously explored.Myrica cerifera
(Myricaceae), “wax myrtle” or “bayberry,” is one of these
important medicinal plants used in folk, ayurveda, and ho-
meopathic systems of medicine for various ailments of the
liver including jaundice and cancer [7]. This plant grows in
the northern and central parts of America, Bermuda, and the
Caribbean, and is used to treat dental problems, stomach-
ache, and constipation, and is also used as a skin cleanser [8].
In addition, it has amarkedaction on the liver, particularly on
jaundice. The plant contains several organic compounds
including diarylheptanoids (myricanone), terpenoids, flavo-
noids, tannins, and phenols [9]. Many diarylheptanoids have
anti-inflammatory effects in various cancer cells [10,11]. A
preliminary screening for theantitumor effect ofmyricanone
has been reported [12]; to our knowledge, however, the
anticancer mechanism of myricanone has yet to be clearly
established. No precise study has yet been conducted to
delineate the molecular mechanism(s) of its possible anti-
cancer effect on HCC cells, particularly in relation to mito-
chondrial membrane potential (MMP) and reactive oxygen
species (ROS) accumulation; furthermore, how myricanone
induces apoptosis through a well-organized signal cascade in
cancer cells is not yet precisely known.
Therefore, the main objectives of the study were to test
whether: (1) the isolated myricanone had any cytotoxicity
against HepG2 cells without affecting the viability of normal
liver cells (WRL-68) in vitro, (2) the isolated myricanone
affected ormodulated depolarization ofMMPand generation
of ROS leading to apoptosis in HepG2 cells, (3) apoptosis in
HepG2 was mediated through cytochrome c release and
HSP70 modulation, and finally, (4) myricanone had any
cytotoxic or hepatoprotective effects in mice in vivo.2. Materials and methods
2.1. Reagents
Dulbecco’s modified Eagle’s medium, fetal bovine serum,
penicillin, streptomycin, neomycin (PSN) antibiotic, trypsin,
and ethylenediaminetetraacetic acid were purchased from
Gibco BRL (Grand Island, NY, USA). Propidium iodide, DAPI
(40,60-diamidino-2 phenyl indole), MTT [3-(4,5-dimethyl-thia-
zol-2-yl)-2, S-diphenyltetrazolium bromide], and all other
chemicals usedwere purchased from Sigma-Aldrich (St. Louis,
MO, USA). All organic solvents used were of HPLC grade.
2.2. Isolation of bioactive fraction and
identification of myricanone from crude ethanolic
extract of M. cerifera
The ethanolic extract of M cerifera is available in the market
as a homeopathic mother tincture. It was purchased from
HAPCO (B.B. Ganguly Street, Kolkata, India). Myricanone was
isolated from the extract of M cerifera by adopting the
methods described by Matsuda et al [13,14] with slight
modifications. Briefly, the extract was evaporated at 30 C.
The dried extract (22 g) was dissolved in methanol, and the
methanol-soluble part was partitioned in an n-butanol/H2O
(1:1 v/v) solvent system. The n-butanol soluble part was
subjected to ordinary phase silica gel (230e400 mM mesh)
column chromatography. The column was then eluted
sequentially with chloroform/methanol (9:1 v/v) solvent
system, and four fractions (F1, F2, F3, and F4) were collected
(200 mL each). Of these fractions, F2 showed maximum
anticancer potential on initial trials (the others had relatively
less potential). For this, the F2 fraction was further subjected
to ordinary phase silica gel column chromatography, then
eluted with hexane/ethyl acetate (7:3 v/v) solvent system,
and five subfractions (F2.1, F2.2, F2.3, F2.4, and F2.5) were
collected (200 mL each). Then it was further purified using
preparative thin layer chromatography and characterized
through Fourier transform infrared (FTIR) and mass spec-
troscopy. The extraction procedure is summarized in Fig. 1.
2.3. Cell culture
Cancer cells of the human HCC cell line (HepG2), and
normal liver cell line (WRL-68) were procured from the
National Centre for Cell Science, Pune, India. Both types of
cells were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum and 1% antibi-
otic (PSN) in a humidified incubator with 5% CO2.
2.4. Cell viability assay
The percentage of viable cells was assessed by following
the standard protocol [15], prior to and after treatment
with myricanone, at a concentration ranging from 20 mg/mL
to 100 mg/mL at a 24-hour interval. Briefly, after 24 hours
of myricanone treatment, cell viability was assessed using
the MTT assay, and the IC50 value was determined. The
intracellular formazan crystals formed were solubilized in
acidic isopropanol, and the absorbance of the solution was
Figure 1 Schematic diagram of myricanone isolation procedure.
190 A. Paul et al.measured at 595 nm. Percentage viability was calculated
as: optical density (OD) of drug treated sample/OD of
control sample  100.
2.5. Treatment types and dose selection
Onthebasis ofMTTresults and IC50 value, threedifferent doses
(D1, 20 mg/mL; D2, 30 mg/mL; D3, 40 mg/mL) of myricanone
were selected for further experiments. For HSP70 protein
expression study, cells were preincubatedwith 10 mMPifithrin-
m (HSP70 inhibitor) [16] for 2 hours prior to drug treatment.
Control groups received only media without any treatment.
2.6. Assessment of apoptosis
2.6.1. Scanning electron microscopic and phase contrast
microscopic analyses
Control and treated cells were washed with phosphate-
buffered saline (PBS) and fixed with 2.5% glutaraldehyde for
2 hours. The cells were then washed three times with PBS and
placed in desiccators overnight. Next, the cells were observedseparately under phase contrast (Leica Microsystems CMS
GmbH, Ernst-Leitz-Straße 17-37, Wetzlar, D-35578 Germany)
and scanning electron microscopes (S530-Hitachi, Tokyo,
Japan).
2.6.2. Nucleosomal fragmentation analysis
Control and treated cells were washed with PBS and stained
with 10 mg/mL DAPI for 10 minutes at 37 C. The images of
stained cells were taken under a fluorescence microscope
(Leica, Germany).
2.6.3. Annexin V-FITC/PI assay
In order to evaluate apoptosis and necrosis, externalization of
phosphatidylserineduringapoptosis and leakage fromnecrotic
cells was observed by Annexin V-FITC/PI (propidium iodide)
dual staining using the standard protocol [15]. Differentiation
of cell population was done on flow cytometer (BD FACS Cal-
ibur, San Jose, CA, USA) andwas assessed as follows: (a) viable
cancer cells (Annexineve; PIeve), (b) early apoptotic cancer
cells (Annexin þve; PI eve), (c) late apoptotic cancer cells
(Annexin þve; PI þve), (d) necrotic cells (PI þve). Samples
wereanalyzedusing theCyflogic (version1.2.1,CyflogicTeam,
Myricanone Induces Apoptosis in HepG2 cells 191Turku, Finland) software, and determinationwas based on the
mean fluorescence intensity of 10,000 events.
2.7. Cell cycle analysis
After 24 hours of myricanone treatment, cells were sus-
pended in PBS and fixed by the addition of 70% ice cold
methanol. The fixed cells were harvested and washed with
PBS; next, RNase (1 mg/mL) was added to the samples,
which were then resuspended in PI stain (10 mg/mL). The
fluorescence was measured at 585 nm. Flow cytometric
data were analyzed using Cyflogic (version 1.2.1) software.
2.8. Detection of intracellular ROS accumulation
and change in MMP (DJm)
Intracellular ROS accumulation and change in DJm were
evaluated through fluorescence microscopy and flow cytom-
etry as described elsewhere [15]. Briefly, intracellular ROS
accumulation and change in DJm were evaluated by fluo-
rescence microscopy. Control and treated cells were fixed in
70% ethanol and incubated for 30 minutes in dark with 20 mM
H2DCFDA (2
0,70-dichlorodihydrofluorescein dichlorodihydro-
fluorescein diacetate) and 10 mMRhodamine 123, respectively.
Then, cells were analyzed under fluorescence microscope.
For the quantitative estimation of ROS and DJm, cells
were fixed in 70% ethanol and incubated with 20 mM
H2DCFDA. And 10 mM Rhodamine 123, respectively, for 30
minutes in the dark. The fluorescence intensity of dye was
determined by flow cytometry using FL1-H filter. Data were
analyzed using Cyflogic (version 1.2.1) software.
2.9. Preparation of cell lysate
Briefly, 1106 cells/mL were lysed in 20 mL ice-cold lysis
buffer [10 mM Trisehydrochloride (HCl), 1 mM magnesium
chloride, 1 mM ethylenediaminetetraacetic acid, 0.1 mM
phenylmethylsulfonyl fluoride, 5 mM b-mercaptoethanol,
0.5% CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate), 10% glycerol]. Cells were incubated for
30 minutes on ice and centrifuged for 20 minutes at 8000 g
at 4 C, and the supernatants were collected and stored at
20 C for further use.
2.10. Cytochrome c activity assay
The cellular lysate was used for the quantification of cyto-
chrome c activity by indirect enzyme-linked immunosorbent
assay (ELISA) as described earlier [17]. Briefly, cells were
coated with anticytochrome c primary antibody and blocked
by 3% bovine serum albumin (BSA) solution. After the sec-
ondary antibody incubation, para-nitrophenylphosphate was
used as a color developer, and color intensity was measured
at 405 nm with respect to blank.
2.11. Immunofluorescence study for detection of
HSP70 expression
Immunoflorescence study was performed using anti-HSP70
primary antibody by following the standard protocol [15].Briefly, at the end of treatments, cells were fixed in 3%
paraformaldehyde for 1 hour. Cells were then permeabilized
with 0.2% CHAPS {3-[3-(cholamidopropyl)dimethylammonio]-
1-proane sulfonate} in PBS for 2 minutes, and cells were
blocked in 3% BSA with 0.2% Tween-20 for 30 minutes. Cells
were then incubated overnight at 4 C with anticytochrome c
primary antibody and observed under fluorescence micro-
scope after incubating with IgG-FITC secondary antibody.
2.12. Preparation of cytosolic and mitochondrial
fractions
Control and treated HepG2 cells were collected, washed
with ice-cold PBS, resuspended in buffer A (10mMTriseMOPS
pH 7.4, 200 mM sucrose, 1 mM EGTA (ethylene glycol tetra-
acetic acid), 1 mg/mL BSA, 1 mM DTT (Dithiothreitol)) and
lysed by homogenization. The suspension was centrifuged
at 1000 g for 10 minutes at 4 C. The resulting supernatant
was centrifuged at 10,000 g for 15 minutes to pellet
mitochondria. Cytosolic fraction (supernatant) was obtained
by centrifugation at 12,000 g for 1 hour at 4 C [18].
2.13. Immunoblot analysis
To analyze the expressions of different proteins,
immunoblot analysis was done using anti-HSP70, cyto-
chrome c, Apaf-1, caspase-9, and caspase-3 antibodies by
following the standard protocol [18]. Alkaline phospha-
tase (ALP)-conjugated secondary antibodies were used
for this purpose. Bound antibodies were developed by 5-
bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazo-
lium (BCIP-NBT), and the band intensity was measured
using Image J software (National Institute of Health, MD,
USA). GAPDH was used as the housekeeping protein.
2.14. Reverse transcriptase-polymerase chain
reaction analysis
Semiquantitative reverse transcriptase-polymerase chain
reaction (RT-PCR) was performed as previously described
[17]. The sequences of the forward and reverse primers
used for specific amplifications were as follows: Bcl-2: (Fwd
50-GTGACTTCCGATCAGGAAGG-30 and Rev 50-CTTCCAGA-
CATTCGGAGACC-30); Bax: (Fwd 50-AGTAACATGGAGCTGCA-
GAGG-30 and Rev 50-ATGGTTCTGATCAGTTCCGG-30) and
GAPDH (Fwd 50-CCCACTAACATCAAATGGGG-30 and Rev 50-
CCTTCCACAATGCAAAGTT-30). The fluorescence intensity of
the bands was measured using the Image J software.
2.15. Animals
Randomized mice (Mus musculus) of Swiss albino strain,
weighing between w20 g and 25 g, were selected and
housed under standard environmental conditions at
ambient temperature of w25 C. The guidelines approved
by the Animal Ethics Committee, University of Kalyani,
were followed in this experiment. Animals were cared for
and supplied with food and water ad libitum. After 1 week
of acclimatization, the mice were used for the experi-
ments. The body weight and food intake data of mice were
192 A. Paul et al.recorded prior to the start and at the end (after 14 days) of
the experiment.
2.15.1. Acute toxicity studies in mice
A group consisting of five mice each is considered optimum
for conducting in vivo experimental research work [19]. For
acute toxicity test, mice divided into three separate groups
(n Z 5) were fed, respectively, with 50 mg/kg, 75 mg/kg,
and 100 mg/kg body weight (bw) of myricanone dissolved in
water. The mortality rate, clinical sign of acute toxicity,
and behavioral changes in mice were monitored over the
14-day period.
2.15.2. Biochemical analysis of serum enzymes
The mice from each group were sacrificed, and blood was
collected by cardiac puncture. The activities of alanine
aminotransferase (ALT) and aspartate aminotransferase (AST)
were analyzed with a spectrophotometer according to the
standard protocols [20]. The activity of ALP was determined
using the appropriate diagnostic kit (Crest Biosystems, Verna,
Goa, India).
2.16. Statistical analysis
The results of all experiments are presented as mean
[standard error (SE)] of values of three independent ex-
periments. Statistical analysis was performed using Student
t test or one-way analysis of variance (ANOVA; Fisher’s least
significant difference (LSD) post-hoc test), where p < 0.05Figure 2 (A) Fourier transform infrared (FTIR) spectrum of isolat
and WRL-68 cells after 24 hours of treatment. Cell viability was m
trazolium bromide) assay (**p < 0.01 and ***p < 0.001 vs control w()), p < 0.01 ())), and p < 0.001 ()))) versus control
were considered significant.3. Results3.1. Characterization of chromatographic fraction
Fourier transform infrared (FTIR) and mass spectroscopic
data showed the F2.2 fraction to be rich in myricanone
[C21H24O5, MS m/z: 356(M-Na)
] [14], which was then
selected for further study. The FTIR data (peak at 3317/cm
represents the OH group, 2854/cm represents the CH2 group,
1713/cm represents the CaO group, 1505/cme1110/cm
represents the aromatic CH group, aliphatic CH3 group) of
the purified myricanone are shown in Fig. 2A.3.2. Effects of myricanone on cell viability
Results of the MTT assay revealed that myricanone had
significant cytotoxic effects on HepG2 cells, whereas it had
no such significant cytotoxic effect on the normal liver cells
(WRL-68) in vitro. The cell viability was gradually
decreased from the minimal drug concentration to the
higher ones. The highest dose of myricanone (100 mg/mL)
showed 12.41% cell viability in HepG2, whereas it was
89.27% for WRL-68 cells. The IC50 value of myricanone in
HepG2 cells was 32.46 mg/mL (Fig. 2B).ed myricanone. (B) Cytotoxic effects of myricanone on HepG2
easured by MTT (3-(4,5-dimethyl-thiazol-2-yl)-2, S-diphenylte-
as considered significant).
Myricanone Induces Apoptosis in HepG2 cells 1933.3. Effect on morphological changes and
nucleosomal fragmentation in HepG2 cells
The morphological changes in myricanone-treated HepG2
cells were analyzed through phase contrast and scanning
electron microscopes (Fig. 3A and B). Typical apoptotic
characteristics such as cellular distortion, cell shrinkage, and
membrane blebbing were observed in a dose-dependent
manner. Cellular distortion was found to be most frequent
at the highest dose.
The untreated HepG2 cells did not take positive staining
with DAPI and showed no cells with visible chromatin
condensation. However, with different concentrations of
treatment, cells with chromatin condensation appeared to
increase in number along with the increase in dose
(Fig. 3C).
3.4. Effect on apoptotic percentage of cells
Apoptosis was confirmed with Annexin V-FITC/PI dual stain-
ing using FACSCalibur (BD Bioscience). After treatment with
myricanone, both early and late apoptotic cells significantly
increased in a dose-dependent manner. The number of
apoptotic cells was increased in a dose-dependent manner
compared to their controls, whereas increase in necrotic
percentage was negligible in all drug-treated cells (Fig. 3D).Figure 3 Myricanone induced apoptosis in HepG2 cells at differen
HeLa cells observed under phase contrast microscopy; arrows indica
scanning electron microscopy. (C) Chromatin condensation observe
nuclear fragmentation. (D) Flow cytometric analysis of apoptosis b3.5. Effect on cell cycle progression
Cell cycle analysis on D1, D2, and D3 of myricanone-treated
HepG2 cells revealed that (Fig. 4) the cells passed through
the mitotic division but were arrested at the G0/G1 phase,
thereby indicating that the diarylheptanoid compound
acted as a G0/G1 phase inhibitor, as also reported in
another study on curcumin [21]. D3 caused higher G0/G1
phase arrest (53.32%) compared to control (42.69%) in
HepG2 cells with consistent decrease in G2/M phase (con-
trol, 35.64%; D3, 22.42%).
3.6. Effect on ROS generation and depolarization of
MMP (DJm) in HepG2 cells
A time-dependent ROS generation was observed by DCFDA
staining. The control cells showed low green fluorescence,
whereas the cells treated with drug showed gradual in-
crease in fluorescence intensity along with increasing time,
reflecting the accumulation of ROS. Quantitative data ob-
tained by flow cytometer would also convincingly support
the previous observation, as the generation of ROS was
found to be increased along with the increase in the period
of drug exposure (Fig. 5A).
DepolarizationofMMPwasmeasuredbothqualitativelyand
quantitatively by Rhodamine 123 staining. The fluorescencet doses (D1, D2, and D3). (A) Overall morphological features of
te apoptotic cells. (B) Morphology of HeLa cells observed under
d under fluorescence microscopy by DAPI staining; arrows show
y Annexin V-FITC/PI staining.
Figure 4 Flow-cytometric analysis of cell cycle at different doses of myricanone. Overlay diagram shows changes in cell cycle
phase with respect to control.
194 A. Paul et al.intensity of treated cells was reduced with respect to control
cells in a time-dependent manner, thereby reflecting the loss
of DJm, which was also confirmed by flow cytometric anal-
ysis, showing a marked decrease in fluorescence intensity
after myricanone (D2) treatment (Fig. 5B).
3.7. Effect on translocation of cytochrome c from
mitochondria to cytosol in HepG2 cells
Translocation of cytochrome c is an important event at the
early stage of the apoptosis pathway. To determine
whether myricanone played a role in the release of cyto-
chrome c from mitochondria into cytosol, the location of
cytochrome c was analyzed. Indirect ELISA showed that
myricanone (D2) caused the release of cytochrome c from
mitochondria into cytosol in a time-dependent manner. The
result revealed that the release of cytochrome c into
cytosol started mainly after 4 hours of myricanone exposure
and the release consistently increased up to 12 hours, and
thereafter a constant release (Fig. 5C) was maintained. A
dose-dependent increase was also confirmed by immuno-
blot analysis (Fig. 5D), as the expression of cytochrome c
was decreased in mitochondrial fraction along with a cor-
responding increase in cytosolic fraction with respect to
control cells (Fig. 5D).
3.8. Effect on regulation of HSP70 expression in
HepG2 cells
In order to determine whether HSP70 played any role in
myricanone-induced apoptosis in HepG2 cells, HSP70 ac-
tivity was assessed by immunofluorescence and immunoblot
analysis. Immunofluorescence analysis showed that the
fluorescence intensity of HSP70 was decreased in a time-
dependent fashion with respect to control (Fig. 6A).
Densitometric analysis of immunoblot showed similar down-
regulation of HSP70 by 0.52-fold (52%) after 24 hours in a
time-dependent manner with respect to control cells
(Fig. 6B). To confirm the effect of HSP70 expression onmyricanone-treated cell viability, HepG2 cells were pre-
treated with pifithrin-m (HSP70 inhibitor). Immunoblot
analysis revealed that there was a 0.51-fold (51%) decrease
in D2-treated cells, whereas a 0.47-fold (47%) decrease in
the case of pifithrin-m only treatment and a 0.42-fold (42%)
decrease in combined pifithrin-m and drug treatment after
24 hours with respect to control (Fig. 6C) were noted.
Immunoblot analysis of HSP70 expression was also down-
regulated after 24 hours of treatment (Fig. 6D) in a dose-
dependent manner with respect to untreated cells.
3.9. Effect on expression of apoptotic signal
proteins
Expression of Apaf-1, caspase-9, and caspase-3 was in-
creased by drug administration in a dose-dependent manner.
For Apaf-1, the expression was enhanced by 1.12-, 1.45-, and
1.61-fold for D1, D2, and D3 drug doses, respectively. In the
case of caspase-9, the expression was enhanced by 1.28-,
1.58-, and 1.79-fold, respectively, and for caspase-3, the
expression was increased by 1.09-, 1.23-, and 1.31-fold,
respectively, with the respective drug dose (Fig. 6E).
3.10. Effect on mRNA expression of pro- and
antiapoptotic genes
The results of RT-PCR showed that myricanone treatment
had up-regulated the mRNA expression of proapoptotic
gene Bax, whereas antiapoptotic Bcl-2 gene expression was
down-regulated in a dose-dependent manner after 24 hours
of treatment (Fig. 6F).
3.11. Effect on general toxicity and enzyme
biomarkers in mice in vivo
No significant changes in food intake, mortality, occurrence
of abnormal clinical signs, symptoms, gain or loss of body
weight, organ weight, etc., were observed in respect of
acute toxicity analysis of myricanone (at tested doses) in
Figure 5 Measurement of reactive oxygen species (ROS), mitochondrial membrane potential (MMP), and cytochrome c trans-
location. (A) Fluorescence photomicrograph by DCFDA staining. (B) Fluorescence intensity by FACSCalibur using Rhodamine123 dye for
the detection of MMP. (C) Cytochrome c assay by enzyme-linked immunosorbent assay to detect translocation of cytochrome c from
mitochondria into cytosol aftermyricanone exposure (*p< 0.05, **p< 0.01 and ***p< 0.001 vs control was considered significant.). (D)
Immunoblot analysis to show translocation of cytochrome c from mitochondria to cytosol. GAPDH was used as a housekeeping gene.
Myricanone Induces Apoptosis in HepG2 cells 195mice over the entire experimental period (14 days). No such
significant changes in the serum activity levels of ALT, AS,
and ALP were also observed in myricanone-treated mice
after the experimental period (Table 1).4. Discussion
After observing the considerable hepatoprotective effects
of crude ethanolic extracts from the bark of M cerifera in
our laboratory (data not shown), we became more inter-
ested in examining if its major bioactive compound,myricanone, could also demonstrate such properties, and if
it did, to learn in more detail about its signaling cascade to
accomplish apoptosis. The present findings showed that
myricanone inhibited the growth of HepG2 cells in a dose-
dependent manner, whereas it had little or no cytotox-
icity on normal liver cells (WRL-68). The ability to induce
apoptosis in cancer cells is considered one of the hallmark
features of many anticancer drugs. In the current study,
myricanone induced an apoptotic response in HepG2 cells
as manifested in the morphological changes, with progres-
sive detachment of cells, cytoplasmic shrinkage, membrane
blebbing, and formation of apoptotic bodies containing
Figure 6 (A) Immunofluorescence study of HSP70 protein reveals that the fluorescence intensity was gradually decreased with an
increase in time. (B) Time-dependent down-regulation of HSP70 expression was also observed by immunoblot study. (C) HSP70
activity was also detected by immunoblot study using Pifithrin-m (HSP70 inhibitor), showing consequent down-regulation of HSP70
expression after drug treatment. (D) Immunoblot expression of HSP70 showed significant down-regulation after myricanone
treatment in a dose-dependent manner. (E) Immunoblot expression of Apaf-1, caspase-9, and caspase-3 showed significant up-
regulation of Apaf-1, caspase-9, and caspase-3 after myricanone treatment in a dose-dependent manner. (F) Reverse
transcriptase-polymerase chain reaction (RT-PCR) analysis of mRNA expression of Bax and Bcl-2 showed up-regulation of Bax and
down-regulation of Bcl-2 activity after myricanone treatment. GAPDH acts as a house keeping gene. The intensity of control was
normalized to 1, and the intensity of each band from treated cells is compared to the control.
196 A. Paul et al.condensed and fragmented chromatin. The analysis of the
apoptotic phenomenon was further confirmed by Annexin
V-FITC/PI assay, where an increase in the population of
cells undergoing apoptosis was noted in a dose-dependent
manner. Concomitantly, the growth rate of the cells was
also found to be reduced at the G0/G1 phase after myr-
icanone treatment, which is in agreement with earlier
findings where curcumin, a diarylheptanoid, showed cell
cycle arrest at the G0/G1 phase in breast cancer cells [21].
By contrast, increase in the generation of ROS has long
been implicated in the apoptotic response induced by
several anticancer agents [22,23]. MMP also plays a critical
role in apoptosis by releasing apoptotic factors. Recently,Table 1 Effect of myricanone on the activity of different serum
Group ALT (units/mL)
Control 13.29  0.84
Myricanone (50 mg/kg bw) 14.98  1.44
Myricanone (75 mg/kg bw) 13.84  0.89
Myricanone (100 mg/kg bw) 13.56  1.14
Data are presented as mean  standard error of five mice (n Z 5) pe
ALP Z alkaline phosphatase; ALT Z alanine aminotransferase; AST Zchemotherapeutic drugs targeting mitochondria has been
hailed as a landmark discovery in cancer therapy [24]. The
present study reveals that treatment with myricanone in-
creases cellular ROS accumulation with concomitant de-
crease in MMP. This shows that myricanone-induced
apoptosis was possibly mediated through ROS generation
and activation of the mitochondria-dependent cell death
pathway. Accumulation of ROS and depolarization of MMP
are concurrent processes that normally induce mitochon-
dria to release cytochrome c to the cytoplasm. It is re-
ported that cytochrome c released from mitochondria
triggers caspase activation, which could be mediated
through the direct or indirect action of ROS [25]. In theenzymes of mice after 14 days.
AST (units/mL) ALP (KA units/mL)
12.12  0.73 5.76  0.35
14.46  0.1.25 6.28  0.22
13.59  0.95 5.78  0.35
14.34  0.72 6.0  0.33
r group.
aspartate aminotransferase.
Myricanone Induces Apoptosis in HepG2 cells 197present study, the early release of cytochrome c after
myricanone treatment would further lend support to this
contention. The release of cytochrome c into cytosol
peaked after 12 hours of treatment, which coincided with a
marked increase in ROS formation and a decrease in MMP.
This would indicate that the initiation of cytochrome c
disposal might be dependent on ROS generation with MMP
disruption and could thereby initiate apoptosis after myr-
icanone treatment.
HSP70 is an important suppressor of apoptosis. Under
normal conditions, HSP70 proteins function as molecular
chaperones. When the cancer cells become resistant to
chemotherapeutic drugs, the synthesis of stress-inducible
HSP70 in the cancer cells enhances their ability to survive
[26]. The cytoprotective role of HSP70 is attributed to its
chaperone activity. It has been demonstrated that direct
binding of Apaf-1 to HSP70 prevents the recruitment of
procaspase-9 to form the apoptosome complex [27]. The
results of our time-dependent immunofluorescence and
immunoblot studies suggest that myricanone inhibited
HSP70 expression and thus enhanced the release of cyto-
chrome c into cytosol and consequently up-regulated the
Apaf-1 expression to form the apoptosome complex and
initiated apoptosis through the caspase-dependent
pathway. Moreover, the expressions of caspase-9 and
caspase-3 were also increased in a dose-dependent
manner. Thus, the present study demonstrates that myr-
icanone treatment altered the levels of HSP70 that could
lead to the loss of control of cell growth and exerted
inhibitory effects on apoptosis in HepG2 cells.
The Bcl-2 family proteins are known to be a regulator of
mitochondrial membrane permeability and polarization,
and also the regulator of the release of cytochrome c in
cytosol from mitochondria to initiate apoptosis [28]. Sig-
nificant modulations in Bax and Bcl-2 expressions upon
myricanone exposure indicate an ultimate imbalance of the
Bax/Bcl-2 ratio that leads to HepG2 cells toward apoptosis,
through MMP depolarization.
As toxicity is generated by most of the chemothera-
peutic drugs used, any anticancer drug having no or insig-
nificant effects either on normal cells in vitro or on test
animals in vivo, is considered acceptable and safe for use
for a considerable period. Our in vivo study showed that
myricanone did not show any palpable cytotoxic effect (at
the tested dose) on mice. The enzyme biomarkers (ALT,
AST, and ALP) also supported the antihepatotoxic role of
myricanone in vivo.
In summary, myricanone triggered apoptotic cell death
in HepG2 cells through generation of ROS and early release
of cytochrome c to cytosol from mitochondria by depolar-
ization of MMP, suppression of HSP70 activity, and elevating
mitochondria-dependent caspase activity to induce
apoptosis in cancer cells. Thus, myricanone has the requi-
site qualities and potential to be considered as a suitable
candidate in formulating an effective anticancer therapy,
particularly that affecting the liver.Conflict of interest
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